NCT03011684View on ClinicalTrials.gov

Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial

PHASE3RecruitingINTERVENTIONAL

Enrollment

309

Participants

Timeline

Start Date

July 21, 2016

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Infertility

Interventions

DRUG

Tamoxifen

Given orally

DRUG

Letrozole

Given orally

Trial Locations (1)

94143

RECRUITING

University of California at San Francisco, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER